Loading candles…
Wockhardt is a global pharmaceutical and biotechnology company involved in drug discovery, manufacturing, and marketing of finished dosage formulations, injectables, biopharmaceuticals, orals, and topical products such as creams and ointments. Its products span multiple therapeutic areas including anti-infectives, diabetes, cardiology, and dermatology. The company conducts dedicated research focused on novel antibiotics to tackle antimicrobial resistance (AMR). Wockhardt operates across key geographies including the UK, USA, and Europe, which represent a significant share of its consolidated revenue.
This page is a live market overview for WOCKHARDT LIMITED (WOCKPHARMA) on the NSE. As a listed security, WOCKHARDT LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for WOCKPHARMA before placing trades on tick2trade.
As of the latest feed, WOCKPHARMA last traded at ₹2,021 on NSE, up ₹46 (2.33%) from the previous close of ₹1,975. Today's session range is ₹1,966.1 – ₹2,028, against a 52-week band of ₹1,086.7 – ₹2,422.3. Traded volume today stands at 5.48L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for WOCKPHARMA in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether WOCKPHARMA is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for WOCKHARDT LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in WOCKPHARMA. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated WOCKPHARMA option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Unaudited Results - Q1-FY26 | Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board o… | 10 Aug 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and Fund Raising | 4 May 2026 |
| Unaudited Results - Q3-FY15 | Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board o… | 10 Feb 2026 |
| Results - Q2 & FY25 | Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015, we wish to inform you that a meeting of the Board of… | 3 Nov 2025 |
| Unaudited Results - Q1-FY25 | Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board o… | 8 Aug 2025 |
| Audited Results - Q4 & FY25 | Pursuant to Regulation 29(1) (a) and (d) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wi… | 29 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.